BOSTON--(EON: Enhanced Online News)--Analysis Group, one of the largest private economics consulting firms in North America, is pleased to announce the promotion of Richard A. Mortimer to Managing Principal.
“Since joining the Boston office in 2001, Richard has devoted himself to ensuring that our clients receive thoughtful, pragmatic, and analytically rigorous solutions to complex issues.”
Dr. Mortimer’s work has focused on health economics, applied microeconomics and industrial organization, and econometrics. He has led many engagements involving sophisticated analyses of large data sets to assess class certification, market definition, liability, and damages.
“We are delighted to recognize the many contributions Richard has made to the firm," said Analysis Group CEO and Chairman Martha S. Samuelson. “Since joining the Boston office in 2001, Richard has devoted himself to ensuring that our clients receive thoughtful, pragmatic, and analytically rigorous solutions to complex issues.”
Dr. Mortimer has provided economic analyses, expert testimony, and support to other experts in numerous matters on behalf of clients in the life sciences and other industries. His work has focused on antitrust litigation related to generic entry and drug pricing, as well as litigation and government investigations related to marketing and to physician and provider payments in the pharmaceutical and medical device industries. He has evaluated economic issues in off-label drug use or medical device and drug adoption and provided expert testimony, as well as presented analyses to U.S. Attorney’s Office investigators, on liability and economic damages related to allegations of improper promotion, kickback, and pricing issues.
Outside of litigation, Dr. Mortimer has developed pricing analyses for pharmaceutical clients and collaborated with academics in authoring several public policy studies related to pharmaceutical and general health care legislation. These have been published in leading peer-reviewed health economics and industrial organization journals, such as Health Affairs, Nature Reviews Drug Discovery, the Journal of Medical Economics, and The Journal of Industrial Economics.
Prior to joining Analysis Group, Dr. Mortimer held research and lecturing positions within the University of California public university system and worked as an economic consultant for Ernst & Young, LLP. He received his Ph.D. in economics from the University of California, Berkeley, and a B.A. in economics from Johns Hopkins University.
About Analysis Group
Analysis Group is one of the largest private economics consulting firms in North America, with more than 700 professionals across 11 offices in the United States, Canada, and China. Since 1981, we have provided expertise in economics, finance, health care analytics, and strategy to top law firms, Fortune 500 companies, and government agencies. Our internal experts, together with our network of affiliated experts from academia, industry, and government, offer our clients exceptional depth of expertise.